A tumor biopsy was then collected 6 days after the cfDNA sample, and MSK-IMPACT analysis confirmed the presence of this AR mutation at a VAF of 0.3%, significantly below the threshold for de novo mutation calling using the MSK-IMPACT assay. Here, AR is linked to neoplasm.